New study aims to help older breast cancer patients make chemotherapy choices
NCT ID NCT05049746
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how women aged 65 and older with early-stage breast cancer decide whether to have chemotherapy before or after surgery. Researchers will use surveys to understand their needs and then create a tool to help patients and doctors make better, shared decisions. The goal is to support high-quality choices tailored to each person's values and risks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
95 people
The number who actually took part.
- Started
-
Feb 2016
- Expected to finish
-
Feb 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
65 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
INCLUSION CRITERIA: Patient Inclusion Criteria * Women aged 65 years or older * Must write and speak English * Must have been diagnosed with Stage I-III breast cancer * Must have made decision to either receive or not receive neoadjuvant or adjuvant chemotherapy * Must be within 3 months of breast cancer neoadjuvant or adjuvant chemotherapy treatment decision * Self-reported no visual or auditory deficits * SUBAIM 2b: Women aged 65 years or older * SUBAIM 2b: Must write and speak English * SUBAIM 2b: Must have been diagnosed with stage I-III breast cancer * SUBAIM 2b: Must be a candidate for chemotherapy or targeted therapy (in the setting of HER2+ breast cancer) * SUBAIM 2b: Must be making a decision regarding chemotherapy * SUBAIM 2b: Self-reported no visual or auditory deficits * PHYSICIAN INCLUSION CRITERIA * Physician for patient recruited to participate in study (physician criteria) Exclusion Criteria: None
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Anatomic stage I breast cancer ajcc V8 are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Weight-Loss drug shield breast cancer Survivors' hearts?
- Fasting during chemo: a new way to boost treatment?
- Gut bacteria may fortify bones in breast cancer therapy
- Digital therapy aims to tame the fear that haunts cancer survivors
- A remote diet and exercise program aims to help rural cancer survivors shed pounds and lower recurrence risk
- Can a vaccine train the immune system to hunt down hidden breast cancer cells?